Charles Schwab Investment Management »

Beam Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 571k 27.22
2023-09-30 $13M 541k 24.05
2023-06-30 $16M 501k 31.93
2023-03-31 $14M 464k 30.62
2022-12-31 $18M 461k 39.11
2022-09-30 $22M 452k 47.64
2022-06-30 $15M 397k 38.71
2022-03-31 $21M 371k 57.30
2021-12-31 $28M 348k 79.69
2021-09-30 $29M 334k 87.01
2021-06-30 $32M 251k 128.71
2021-03-31 $18M 220k 80.04
2020-12-31 $17M 204k 81.64
2020-09-30 $4.2M 172k 24.62
2020-06-30 $2.3M 83k 28.00
2020-03-31 $469k 26k 18.04